Determining ED90 of Flumazenil for Selective Respiratory Distress Improvement Using Remimazolam During Endoscopic

Hyun Il Kim1, Da Hyun Jung2, Sung Jin Lee1

  • 1Department of Anesthesiology and Pain Medicine, Severance Hospital, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Republic of Korea.

Cancers
|January 25, 2025
PubMed
Abstract

Insights

Low doses of flumazenil effectively improved respiratory distress in patients receiving remimazolam during monitored anesthesia care (MAC). The study determined the effective dose (ED90) of flumazenil for this specific application.

Area of Science:

  • Anesthesiology
  • Pharmacology

Background:

  • Patients undergoing endoscopic submucosal dissection under monitored anesthesia care (MAC) with remimazolam may experience respiratory distress.
  • Low-dose flumazenil has shown potential to improve respiratory distress without fully reversing sedation in these cases.

Purpose of the Study:

  • To determine the effective dose 90 (ED90) of flumazenil for selectively improving respiratory distress in patients receiving remimazolam for MAC.

Main Methods:

  • A biased-coin up-and-down design was employed for flumazenil dose determination, starting at 5 mcg.
  • Improvement in respiratory distress was recorded within 30 seconds of administration.
  • Centered isotonic regression was used to estimate the ED90.

Main Results:

  • The estimated ED90 of flumazenil was 76.72 mcg (95% CI: 68.07-102.62).
  • Memory recall was infrequent (15%) in patients near the ED90 dose range.
  • No major postoperative complications were observed within 2 days.

Conclusions:

  • The ED90 of flumazenil for alleviating respiratory distress during remimazolam-induced MAC was determined to be 76.7 mcg.
  • Flumazenil effectively improved respiratory distress without reversing consciousness.
  • Findings offer guidance for managing sedation in patients undergoing MAC.

Related Concept Videos

Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
462
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
144
Inhalational Anesthetics: Overview01:20

Inhalational Anesthetics: Overview

Inhalation anesthetics are drugs that induce general anesthesia upon inhalation. They work by increasing the sensitivity of GABAA receptors or inhibiting NMDA receptors, leading to a decrease in central nervous system activity. The depth of anesthesia can be rapidly adjusted by changing the concentration of the inhaled gas. Some common examples of inhalational anesthetics include volatile liquids like isoflurane, desflurane, sevoflurane and gases like xenon and nitrous oxide. Isoflurane, a...
169
Drug Delivery: Enteral Route01:18

Drug Delivery: Enteral Route

The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
374
Stages of General Anesthesia01:22

Stages of General Anesthesia

Various sedation levels offer significant advantages in facilitating procedural interventions for patients undergoing medical or invasive surgical procedures. These levels span from anxiolysis to general anesthesia, providing a spectrum of sedative effects to cater to specific patient needs. Anxiolysis reduces anxiety and is achieved through minimal sedation, enabling patients to remain awake and responsive while feeling more at ease during the procedure. This level can benefit minor...
352
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
95